Trending Now
Tiny Apparel Stock that Could be a Big Opportunity in the...
Of all the trends to watch for investors coming out of the pandemic, the apparel industry could be one of the most...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Arbutus Biopharma Corporation (NASDAQ:ABUS) Announces Q3 2020 Results and Updates On...
Arbutus Biopharma Corporation (NASDAQ:ABUS) has reported its Q3 2020 financial results and also provided a business update.
Arbutus evaluating AB-729 in HBV
The company's CEO and...
MAKE IT MODERN
LATEST REVIEWS
Investing in Emerging Ad Tech Opportunities (PUBM, CRTO, CMGR, MGNI)
The Ad industry is rapidly evolving before our eyes. But evolution is nothing new to this space. It has always been in...
MAKE IT MODERN
PERFORMANCE TRAINING
Selecta Biosciences Inc (NASDAQ:SELB) Will Advance Gene Therapy Program In H1 2021 In MMA:...
Selecta Biosciences Inc (NASDAQ:SELB) posts a loss of $24.1 million in Q2 2020. Its general and administrative expenses in Q2 2020 are $5.6 million,...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives the First Milestone Payment from a Commercial Sale of...
The founding of PTC Therapeutics, Inc. (NASDAQ:PTCT), Inc over 20 years ago was driven by the need to create: a patient-centric approach to treating...
Moderna Inc (NASDAQ: MRNA) Demonstrates Improved Immune Response In Adolescents In Phase 2/3 Clinical...
Moderna Inc (NASDAQ: MRNA) demonstrated the safety of its COVID-19 vaccine in adolescents.
The company conducted a phase 2/3 clinical trial of its COVID-19 vaccine...
Bluebird Bio Inc. (NASDAQ:BLUE) Receives PRIME Designation From EMA For Advancement Od LentiGlobin™ For...
Bluebird Bio Inc. (NASDAQ:BLUE) has announced that it has received eligibility from the European Medicines Agency to the Priority Medicines program (PRIME) for its...
Humanigen Inc. (NASDAQ:HGEN) Enters Partnership With Thermo Fisher To Scale Manufacturing For Lenzilumab
Humanigen Inc. (NASDAQ:HGEN) has announced the signing of a strategic partnership deal with Thermo Fisher Scientific to expand the manufacturing capacity for lenzilumab. The...
MAKE IT MODERN
